Categories
- ALS Treatment
- Ataxia Treatment
- Autism Treatment
- Batten Disease Treatment
- Brain Injury Treatment
- Cerebral Palsy Treatment
- Epilepsy Treatment
- Femtomedicine
- genetic-medicine
- Hormone Replacement Therapy
- MS Treatment
- Muscular Dystrophy Treatment
- Nanomedicine
- Parkinson's Treatment
- Picomedicine
- Spinal Cord Injury Treatment
- Stem Cell Research
- Stem Cell Therapy
- Stroke Treatment
- Uncategorized
Archives
Recommended Sites
- Affordable Web Hosting
- Bed Bug Registry
- Bing Search
- Broken Link Checker
- Browser Shots
- Cancer Specialist
- Conscious Evolution
- Cryomedical Blog
- Free Health Insurance Quote
- Free Loan Quote
- Genistein Net
- Google Search
- HGH
- HGH Injections
- HGH Prescription
- HGH Side Effects
- HGH Therapy
- Hormone Therapy
- Human Growth Hormone
- Injectable Testosterone
- Medical School Review
- Miami Spray Tanning
- New York City Real Estate
- Palm Beach Real Estate
- POLIMEDICAL CENTRO POLISPECIALISTICO
- Ron Paul 2012
- Ron Paul TV
- SEO Web Design
- Start Your Own Internet Services Company
- Testosterone
- Testosterone Therapy
- Topamax Lawsuit
- Weight Loss
- WholeSale Domain Names
- Yahoo Search
-
Category Archives: Muscular Dystrophy Treatment
Ligand Licenses DARA Program to Retrophin
SAN DIEGO & NEW YORK–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND – News) and Retrophin, LLC announced that the companies have entered into an agreement in which Ligand has licensed rights to DARA (a Dual Acting Receptor Antagonist of Angiotensin and Endothelin receptors) to Retrophin. Under the terms of the agreement, Ligand will receive a net upfront payment of $1 million, and may receive, net of amounts owed to third parties, over $75 million in milestone payments based on clinical and regulatory progress as well as 9% in royalties on potential future worldwide sales by Retrophin. “DARA has the promise to be a significant medicine, and we are excited to partner with Retrophin to advance the development of the program and bring it closer to patients in need,” said John Higgins, President and Chief Executive Officer of Ligand Pharmaceuticals. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-pivotal-trial, agreement, development, focal-segmental, pharmaceuticals, photos, president, press, retrophin, york
Comments Off
Cure Duchenne Announces Three New Funded Research Projects to Help Develop Treatments and Find a Cure for Duchenne …
Newport Beach, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) — CureDuchenne, a nonprofit organization that raises awareness and funds multiple research and development projects to cure Duchenne muscular dystrophy, announces the funding of three new research projects following its third annual CureDuchenne Scientific Summit. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-catalyst-for, a-leading-cause, a-mouse-model, a-study-with, design, development, mouse-model, project, reformulation, specific, spironolactone, transgenic
Comments Off
Parent Project Muscular Dystrophy Awards $500,000 to Tivorsan Pharmaceuticals
To: HEALTH, MEDICAL AND NATIONAL EDITORS Grant Funds Work of Tivorsan Pharmaceuticals' Team to Bring Recombinant Biglycan to the Clinic for the Possible Treatment of Duchenne Muscular Dystrophy HACKENSACK, N.J., Feb. 21, 2012 /PRNewswire-USNewswire/ — Parent Project Muscular Dystrophy (PPMD) announced today that it will award Tivorsan Pharmaceuticals (Tivorsan) a $500,000 grant to develop the company's biglycan therapeutic candidate for Duchenne muscular dystrophy. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged development, duchenne, duchenne-grant, financial, muscular-dystrophy, parent, parent-project, potential, president, project, tivorsan-pharmaceuticals-, voice, work
Comments Off
Dateline Long Beach: The Aquatic Center brings swim therapy to disabled
Xiara Leiva, a swim instructor at the California Aquatic Therapy & Wellness Center in Long Beach, works with Joey Perez, l3, who has autism as well as muscular dystrophy and is terminally ill. (Sean Hiller / Staff Photographer) As instructors lift Joey from his wheelchair and place him in the warm pool water, a remarkable transformation takes place Continue reading
Posted in Muscular Dystrophy Treatment
Tagged children, depression, people, pool, pools, shoes, wellness-center, wife
Comments Off
Medical clinics offer help for Big Island children
BY CHELSEA JENSEN WEST HAWAII TODAY cjensen@westhawaiitoday.com Shriners Hospital for Children is headed to the Big Island to connect pediatric doctors with young patients who need their specialized care. The Honolulu-based hospital, which serves Hawaii and the Asia and Pacific regions, will have outreach clinics at two West Hawaii locations Feb. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-more-normal, among-the-most, asia-, children, hawaii-island, hilton, honolulu, hospital, keauhou, making-the-trip, musculoskeletal, sandy-zukeran, trip
Comments Off
When nerve meets muscle, biglycan seals the deal
The protein biglycan needs to be present to stabilize synapses at the neuromuscular junction after they have formed, according to research led by Brown University that appears in the Feb. 14, 2012, issue of the Journal of Neruoscience. “What neuromuscular junctions do second-by-second is essential for our brain to control movement and they are also important for the long-term health of both muscle and motor neurons,” said Justin Fallon, profesor of neuroscience at Brown University and the paper's senior author. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-folds-near, brown-, brown-institute, brown-university, experiment, fallon, health, journal, neuromuscular, paper, providence, receptor-enzyme, scientists, structural, such-as-spinal
Comments Off
JumpStart Invests $250,000 in Milo Biotechnology
CLEVELAND, Feb. 14, 2012 /PRNewswire/ – Milo Biotechnology will receive $250,000 from JumpStart Inc., a nonprofit investing intensive business assistance and some capital into early stage Northeast Ohio-based tech companies. A clinical stage startup developing a therapy to increase muscle strength and improve the quality of life of muscular dystrophy patients, Milo is the 61st company in JumpStart's portfolio. ”There are limited treatment options for muscular dystrophy and approved therapies are inadequate or can cause significant side effects,” says JumpStart's Mike Lang Continue reading
Posted in Muscular Dystrophy Treatment
Tagged a-grant-from, biotechnology, cleveland-based, follistatin, northeast-ohio, parent, parent-project, research-, start-inc-
Comments Off
Amicus Therapeutics Awarded Grant From Muscular Dystrophy Association for Pompe Disease Program
CRANBURY, N.J. — Amicus Therapeutics , a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, today announced the receipt of a two-year, $186,000 grant from the Muscular … Continue reading
Posted in Muscular Dystrophy Treatment
Tagged amicus, amicus-therapeutics, announced-the-receipt, forefront, from-the, from-the-muscular, muscular, orphan-diseases, rare-and, receipt, the-forefront, the-receipt, therapies-for, today-announced
Comments Off
Alyssa Hansen | Mitt Romney takes on medical marijuana
Presidential GOP candidate Mitt Romney has explicitly expressed his dissension around medicinal marijuana in his campaign despite its numerous benefits. Continue reading
Posted in Muscular Dystrophy Treatment
Tagged campaign, despite-its, dissension, dissension-around, explicitly-expressed, expressed-his, gop, has-explicitly, his-campaign, medicinal-marijuana, numerous-benefits-, romney
Comments Off